申请人:Coudert Gerard
公开号:US20060003997A1
公开(公告)日:2006-01-05
A compound selected from those of formula (I):
wherein:
W
1
, with the carbon atoms to which it is bonded, represents phenyl or pyridyl,
Z represents a group selected from hydrogen, halogen, linear or branched (C
1
-C
6
)alkyl, aryl, aryl-(C
1
-C
6
)alkyl, aryloxy, aryl-(C
1
-C
6
)alkoxy, hydroxy and linear or branched (C
1
-C
6
)alkoxy,
R
1
is as defined in the description,
R
2
represents hydrogen or —CH
2
CH
2
O—R
8
,
R
3
and R
4
each represents hydrogen, linear or branched (C
1
-C
6
)alkyl, aryl or aryl-(C
1
-C
6
)alkyl, n represents an integer of from 1 to 6 inclusive, its isomers, and addition salts thereof with a pharmaceutically acceptable acid or base, and medicinal products containing the same which are useful in the treatment of cancer.
从以下公式(I)中选出的一种化合物:其中:W1,与其结合的碳原子,代表苯基或吡啶基,Z代表从氢、卤素、直链或支链(C1-C6)烷基、芳基、芳基-(C1-C6)烷基、芳氧基、芳基-(C1-C6)氧基、羟基和直链或支链(C1-C6)氧基中选出的一个基团,R1如描述中所定义,R2代表氢或-CH2CH2O-R8,R3和R4各自代表氢、直链或支链(C1-C6)烷基、芳基或芳基-(C1-C6)烷基,n代表从1到6的整数,其异构体,以及其与药学上可接受的酸或碱形成的加合物,以及含有这些化合物的治疗癌症的药物产品。